Blood Disorder News and Research

RSS
ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Enrollment complete in HemaQuest HQK-1001 Phase 2 study in sickle cell disease

Enrollment complete in HemaQuest HQK-1001 Phase 2 study in sickle cell disease

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Researchers identify elusive gene responsible for Grey Platelet Syndrome

Researchers identify elusive gene responsible for Grey Platelet Syndrome

Researchers discover novel combination of two mutations in a patient with ADHD

Researchers discover novel combination of two mutations in a patient with ADHD

Alexion second quarter net product sales of Soliris increase to $185.7 million

Alexion second quarter net product sales of Soliris increase to $185.7 million

Young people with serious genetic blood disorder are not getting right help at school

Young people with serious genetic blood disorder are not getting right help at school

New genetic research holds promise for patients with Chuvash polycythemia

New genetic research holds promise for patients with Chuvash polycythemia

Alexion begins eculizumab clinical trial in Shiga-toxin producing E. coli hemolytic uremic syndrome

Alexion begins eculizumab clinical trial in Shiga-toxin producing E. coli hemolytic uremic syndrome

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

UAB first in U.S. with cell-processing workstation

UAB first in U.S. with cell-processing workstation

Alexion's sBLA for Soliris receives FDA Priority Review designation to treat aHUS

Alexion's sBLA for Soliris receives FDA Priority Review designation to treat aHUS

Birth control pill safety issues raised

Birth control pill safety issues raised

CSL-Behring recombinant factor research presented

CSL-Behring recombinant factor research presented

Doctors miss blood clots costing millions to the NHS: Report

Doctors miss blood clots costing millions to the NHS: Report

Hyponatremia linked to high risk of fractures in elderly patients

Hyponatremia linked to high risk of fractures in elderly patients

HemaQuest initiates HQK-1001 Phase 2 study in sickle cell disease

HemaQuest initiates HQK-1001 Phase 2 study in sickle cell disease

Alexion first quarter non-GAAP net income increases to $56.3 million

Alexion first quarter non-GAAP net income increases to $56.3 million